Jianing Li

State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction to: Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Correction to: Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Journal: BMC cancer

Published: August 13, 2026

Association of neurite orientation dispersion and density imaging with cognitive impairment in nasopharyngeal carcinoma patients with radiation-induced temporal lobe injury.

Association of neurite orientation dispersion and density imaging with cognitive impairment in nasopharyngeal carcinoma patients with radiation-induced temporal lobe injury.

Journal: Frontiers in human neuroscience

Published: February 11, 2026

Multi-armored mesenchymal stem cells potentiate antitumor immunity to combat ovarian cancer.

Multi-armored mesenchymal stem cells potentiate antitumor immunity to combat ovarian cancer.

Journal: Stem cell research & therapy

Published: October 15, 2025

Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas.

Time-dependent diffusion MRI for differentiating non‑small cell lung‑cancer brain metastases from breast‑cancer brain metastases and gliomas.

Journal: Neuroradiology

Published: July 09, 2025

Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells.

Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells.

Journal: International journal of biological sciences

Published: May 21, 2025

NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair.

NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair.

Journal: Oncogene

Published: May 09, 2025

Facile construction of manganese-based contrast agent with high T 1 relaxivity for magnetic resonance imaging via flash technology-based self-assembly.

Facile construction of manganese-based contrast agent with high T 1 relaxivity for magnetic resonance imaging via flash technology-based self-assembly.

Journal: Regenerative biomaterials

Published: November 18, 2024

N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.

N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.

Journal: Journal of biomedical science

Published: July 22, 2024

CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.

CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.

Journal: Journal for immunotherapy of cancer

Published: November 19, 2023

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.

Journal: Oncogene

Published: July 25, 2023

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Journal: BMC cancer

Published: May 15, 2023

Upregulating HIF-1α to Boost the Survival of Neural Stem Cells via Functional Peptides-Complexed MRI-Visible Nanomedicine for Stroke Therapy.

Upregulating HIF-1α to Boost the Survival of Neural Stem Cells via Functional Peptides-Complexed MRI-Visible Nanomedicine for Stroke Therapy.

Journal: Advanced healthcare materials

Published: July 05, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026